The Spanish Association of Biosimilar Medicines (BioSim) has held the V National Biosimilars Conference under the title 'Improving management, accelerating access'. During the inauguration, the president of BioSim, Joaquín Rodrigo, wanted to make a call to health administrations, reminding that, 'so that the biosimilar market is a sustainable market and can continue to play its role as regulators of the pharmaceutical market and facilitators of access to biological therapies, it is necessary to establish measures that allow certain volumes to be maintained.'
recently published
